Issitt PD. Race-related red cell
alloantibody problems. Br J Biomed Sci 1994 Jun;51(2):158-67.
[ Medline
]Kiefel V, Konig C, Kroll H,
Santoso S. Platelet
alloantibodies in transfused patients. Transfusion. 2001
Jun;41(6):766-70. [ Full text
] [ Medline
]
Olujohungbe A, Hambleton
I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in
patients with homozygous sickle cell disease: a comparison of
patients in Jamaica and the United Kingdom. Br J Haematol 2001
Jun;113(3):661-5. [ Medline
]
Reid ME, Oyen R, Marsh WL. Summary of the
clinical significance of blood group alloantibodies. Semin
Hematol 2000 Apr;37(2):197-216.
Schonewille, H., Haak, H.L., van Zijl,
A.M. Alloimmunization
after blood transfusion in patients with hematologic and
oncologic diseases. Transfusion 1999 Jul; 39(7): 763-71.
[ Full text
] [ Medline
]
Schonewille H, Haak HL, van
Zijl AM. RBC antibody persistence. Transfusion 2000
Sep;40(9):1127-31. [ Full text
] [ Medline
]
Singer S T, Wu V, Mignacca R,
Kuypers FA, Morel P, Vichinsky EP. Alloimmunization
and erythrocyte autoimmunization in transfusion-dependent
thalassemia patients of predominantly Asian descent.
Blood, 2000 15 Nov;96(10): 3369-73.
Winters JL, Pineda AA,
Gorden LD, Bryant SC, Melton LJ III, Vamvakas EC, et al. RBC
alloantibody specificity and antigen potency in Olmstead
County, Minnesota. Transfusion, 2001 Nov;41(11):
1413-20. [ Full text
] [ Medline
]
